-
Neuralink plans to implant its brain chip in a second human patient within the next week.
-
The company is working to resolve hardware issues encountered in the first trial.
-
Neuralink aims to implant the chip in “high single digits” of patients this year.
Neuralink, a company founded by Elon Musk, is preparing to implant its brain chip in a second human patient. This announcement was made during a livestream on X, with Musk and other top executives sharing updates on the company’s progress. The first human trial was conducted earlier this year on a 29-year-old man who was paralyzed from the shoulder down.
The Neuralink brain chip, called Telepathy, has 64 threads that are inserted directly into the brain to record neural signals. The company has received approval from the U.S. Food and Drug Administration to commercialize its devices. Neuralink is taking measures to minimize risks, including skull sculpting and reducing carbon dioxide concentration in the blood.
The company’s goal is to implant the chip in several patients this year, with the exact timeline yet to be announced. Neuralink’s brain-computer interface technology has the potential to revolutionize the treatment of paralysis and other neurological conditions. As the company continues to advance its technology, it’s important to stay informed about the latest developments and breakthroughs.
— Neuralink (@neuralink) July 10, 2024
